Frequency of the ASN-108 and THR-108 point mutations in the dihydrofolate reductase gene in Plasmodium falciparum from southwest Colombia

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 1, 1998, Pages 124-128

  Giraldo, Luis E ^a   Acosta, Marta C ^a   Labrada, Luz A ^a   Praba, Anita ^a   Montenegro James, Sonia ^a   Saravia, Nancy G ^a   Krogstad, Donald J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; DIHYDROFOLATE REDUCTASE; FANSIDAR; FOLIC ACID ANTAGONIST; PROGUANIL; PYRIMETHAMINE; SERINE; THREONINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; COLOMBIA; FEMALE; FREQUENCY ANALYSIS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TREATMENT FAILURE;

EID: 0031746084     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.124     Document Type: Article

References (25)

1. Wyler DJ, 1983. Malaria: resurgence, resistance and research. N Engl J Med 308: 875-878 and 934-940.
2. World Malaria Situation in 1993, 1996. Wkly Epidemiol Rec 3: 17-22.
3. Foote SJ, Cowman AF, 1994. The mode of action and mechanism of resistance to antimalarial drugs. Acta Trop 56: 157-171.
4. Salako LA, Risquat AA, Sowunmi A, Walker O, 1990. Parenteral sulphadoxine-pyrimethamine (Fansidar®): an effective and safe but under-used method of anti-malarial treatment. Trans R Soc Trop Med Hyg 84: 641-643.
5. Espinal C, Uribe LM, Eslava A, Rodiguez ME, 1981. Resistencia del P. falciparum a la combinación sulfadoxina-pirimetamina: descripción de los 3 primeros casos en Colombia. Biomedica 1: 213-217.
6. Botero D, Restrepo M, Montoya A, 1985. A prospective double blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine and pyrimethamine-sulfadoxine alone in treatment of falciparum malaria. Bull World Health Organ 63: 731-737.
7. Espinal CA, Cortes GT, Guerra P, Arias AE, 1985. Sensitivity of Plamodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg 34: 675-680.
8. Soto J, Martinez R, Fonschiffrey G, Dember J, 1995. Efficacy of Fansidar® for acute uncomplicated malaria due to Plasmodium falciparum in Colombia. Trans R Soc Trop Med Hyg 89: 306.
9. Peterson DS, Walliker D, Wellems TE, 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85: 9109-9113.
10. Cowman AF, Morry MJ, Biggs BA, Cross GAM, Foote SJ, 1988. Amino acid change linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 85: 9114-9118.
11. Foote SJ, Galatis D, Cowman AF, 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in the cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87: 3014-3017.
12. Peterson DS, Milhous WK, Wellems TE, 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87: 3018-3022.
13. Zolg JW, Chen GX, Plitt R, 1990. Detection of pyrimethamine resistance in Plasmodium falciparum by mutation-specific polymerase chain reaction. Mol Biochem Parasitol 39: 257-265.
14. Peterson DS, Di Santi SM, Povoa M, Calvosa VS Do Rosario VE, Weliems TE, 1991. Prevalence of the dihydrofolate reductase Asn-108 mutation as basis for pyrimethamine resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 45: 492-497.
15. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, 1995. Pyrimethamine and proguanil resistance conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.
16. Kain KC, Wirtz RA, Fernandez I, Franke DE, Rodriguez MH, Lanar DE, 1992. Serological and genetic characterization of Plasmodium vivax from whole blood-impregnated filter paper discs. Am J Trop Med Hyg 46: 473-479.
17. Wooden J, Kyes S, Silbley CH, 1993 PCR and strain identification in Plasmodium falciparum. Parasitol Today 9: 303-305.
18. Snounou G, 1995. Detection and identification of the four malaria parasites species infecting human by PCR amplification. Clapp JP, ed. Methods in Molecular Biology. Totowa, NJ: Human Press Inc., 263-291.
19. Triglia T, Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153.
20. Barker RH Jr, Banchogaksorn T, Courval JM, Suwonkerd W, Rimwungtragoon K, Wirth DF, 1994. Plasmodium falciparum and P. vivax: factors affecting sensitivity and specificity of PCR-based diagnosis of malaria. Exp Parasitol 79: 41-49.
21. Blair S, 1986. Resistencia de P. falciparum a drogas en Colombia 1961-1986, Biomedica 6: 95-100.
22. Alecrim MG, Alecrim WD, Albuquerque BC, Dourdo HV, Wanass MC, 1982. Resistencia do Plasmodium falciparum na amazonia brasileira a associacao sulfadoxina mais pirimetamina. Rev Inst Med Trop Sao Paulo 24: 44-47.
23. Kremsner PG, Zatter GM, Feldmeir H, Graninger W, Kollaritsch M, Weidermann G, Rocha RM, Wernsdorfer WH, 1989. In vitro drug sensitivity of Plasmodium falciparum in Acre, Brazil. Bull World Health Organ 67: 289-293.
24. Basco LK, de Pecoulas PE, Wilson CM, Le Bras J, Mazabraud A, 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69: 135-138.
25. Wernsdorfer WH, 1994. Epidemiology of drug resistance in malaria. Acta Trop 56: 143-156.